These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12695282)

  • 21. Is coronary artery bypass grafting the treatment of choice for diabetic patients with multivessel disease? No.
    Malik I
    BMJ; 2010 Dec; 341():c6975. PubMed ID: 21149467
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study.
    Solomon SD
    Circulation; 2010 Jun; 121(22):2453-5. PubMed ID: 20530024
    [No Abstract]   [Full Text] [Related]  

  • 23. Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities.
    Sobel BE;
    Am J Cardiol; 2006 Jun; 97(12A):53G-58G. PubMed ID: 16813738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
    Hlatky MA; Melsop KA; Boothroyd DB;
    Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease.
    Harskamp RE; Wang TY; Bhatt DL; Wiviott SD; Amsterdam EA; Li S; Thomas L; de Winter RJ; Roe MT
    Am Heart J; 2014 Mar; 167(3):355-362.e3. PubMed ID: 24576520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma.
    Kuntz RE
    Circulation; 1999 Feb; 99(7):847-51. PubMed ID: 10027803
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?
    Kassimis G; Bourantas CV; Tushar R; de Maria GL; Davlouros P; Hahalis G; Alexopoulos D; Banning AP
    Hellenic J Cardiol; 2017; 58(3):178-189. PubMed ID: 28212871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary artery revascularisation: selecting the appropriate strategy.
    Adams MR
    Intern Med J; 2013 Jan; 43(1):18-22. PubMed ID: 23324088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.
    Celik T; Iyisoy A; Yuksel UC; Isik E
    Int J Cardiol; 2009 Jan; 131(2):269-70; author reply 271-2. PubMed ID: 17692947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for percutaneous and surgical revascularisation: how far does the evidence base guide us?
    Schofield PM
    Heart; 2003 May; 89(5):565-70. PubMed ID: 12695476
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetes mellitus and coronary revascularization procedures.
    Anastasiadis K; Moschos G
    Int J Cardiol; 2007 Jun; 119(1):10-4. PubMed ID: 17156868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifications of coronary risk factors.
    Albu J; Gottlieb SH; August P; Nesto RW; Orchard TJ;
    Am J Cardiol; 2006 Jun; 97(12A):41G-52G. PubMed ID: 16813737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease.
    Rutter MK; Nesto RW
    Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment.
    Bourassa MG; Roubin GS; Detre KM; Sopko G; Krone RJ; Attabuto MJ; Bjerregaad P; Bolling S; Herman MV; Frye R
    Am J Cardiol; 1995 Mar; 75(9):3C-8C. PubMed ID: 7892820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of coronary artery bypass surgical procedure and coronary angioplasty in treatment of coronary artery disease: changes during a 10-year period at Mayo Clinic Rochester.
    Harris WO; Mock MB; Orszulak TA; Schaff HV; Holmes DR
    Mayo Clin Proc; 1996 Oct; 71(10):927-35. PubMed ID: 8820766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary intervention "dominates" coronary artery bypass graft surgery for high-risk patients: good news for patients, a challenge for healthcare planners.
    Radford MJ
    Circulation; 2006 Sep; 114(12):1229-31. PubMed ID: 16982950
    [No Abstract]   [Full Text] [Related]  

  • 37. Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Be Treated With Coronary Artery Bypass Grafting.
    Zakkar M; George SJ; Ascione R
    Circulation; 2016 May; 133(18):1807-16. PubMed ID: 27143547
    [No Abstract]   [Full Text] [Related]  

  • 38. The Bypass Angioplasty Revascularization Investigation (BARI) trial: implications for clinical practice.
    Whitlow PL
    Cleve Clin J Med; 1997 Jan; 64(1):17-20. PubMed ID: 9014379
    [No Abstract]   [Full Text] [Related]  

  • 39. The FREEDOM trial: in appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI.
    Aggarwal B; Goel SS; Sabik JF; Shishehbor MH
    Cleve Clin J Med; 2013 Aug; 80(8):515-23. PubMed ID: 23908108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Putting ad hoc PCI on pause.
    Nallamothu BK; Krumholz HM
    JAMA; 2010 Nov; 304(18):2059-60. PubMed ID: 21063016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.